Combining ‘deep sector expertise with a commercial, solutions-focused approach’, GSK Stockmann is gaining traction among fund clients and international referring law firms for its ability to provide strong local knowledge and an international outlook on transactions and ancillary advice including management incentive schemes. This manifests itself on both private equity deals as well as on early stage matters, with Marcus Peter noted for his expertise at advising on domestic venture capital fintech start-up matters. Anna Gassner co-heads the team alongside Peter and is recognised as a ’real deal-maker’.

Legal 500 Editorial commentary

Accolades

Client satisfaction: Lawyer & team quality

Testimonials

Collated independently by Legal 500 research team.

'What makes them unique is the balance between international resources and boutique agility, giving clients tailored advice with real commercial value. They stand out for their collaborative culture, innovative billing flexibility, and effective use of technology to streamline processes and deliver results quickly.'
'Anna Gassner is a real deal-maker and knows how to identify the main issues and propose feasible solutions which fit all parties.'
'They consistently provide clear, practical guidance rather than just theoretical advice, which sets them apart from many competitors. In particular, the partners demonstrate strong leadership and deep market insight, while the associates are thorough, proactive, and highly engaged.'
'Together, the team shows a rare combination of technical excellence, client focus, and approachability, which I have greatly valued.'
'GSK Stockmann’s private equity practice combines deep sector expertise with a commercial, solutions-focused approach. The team is responsive, pragmatic, and strategic, with strong cross-border capabilities that allow them to handle complex transactions efficiently.'

Key clients

EQT
Nordic Real Estate Partners
Fosun Capital
Vicenda
Universal Investment
Triton
FINVIA
Hauck & Aufhäuser
China Three Gorges
Target Global
Branded
Trade Asset Securitisation Company S.à r.L

Work highlights

Advised the Lebara group in connection with its buyout by Waterland Private Equity from the main existing owners Alchemy and Triton Partners.

Advising Serb Pharmaceuticals, a global specialty pharmaceutical company focused on medicines for rare diseases and medical emergencies and held by private equity firm Charterhouse Capital Partners since 2019 (besides Mérieux and Partners Group, as well as management), on matters including several share capital increases, mergers as well as financing documentation aspects.

Provide ongoing advice to Alchemy Capital Partners in connection with the establishment of Alchemy Step Hotel Group, an investment platform focused on special situations in the European hotel sector, a partnership between Alchemy Special Opportunities LLP and Step Partners GmbH.